EE200200037A - Mitmeannuselised erütropoetiinipreparaadid - Google Patents

Mitmeannuselised erütropoetiinipreparaadid

Info

Publication number
EE200200037A
EE200200037A EEP200200037A EEP200200037A EE200200037A EE 200200037 A EE200200037 A EE 200200037A EE P200200037 A EEP200200037 A EE P200200037A EE P200200037 A EEP200200037 A EE P200200037A EE 200200037 A EE200200037 A EE 200200037A
Authority
EE
Estonia
Prior art keywords
formulations
dose erythropoietin
erythropoietin formulations
dose
phenoxyethanol
Prior art date
Application number
EEP200200037A
Other languages
English (en)
Inventor
Gayed Atef
Original Assignee
Aventis Pharmaceuticals Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharmaceuticals Inc. filed Critical Aventis Pharmaceuticals Inc.
Publication of EE200200037A publication Critical patent/EE200200037A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1816—Erythropoietin [EPO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Hematology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
EEP200200037A 1999-07-22 2000-07-21 Mitmeannuselised erütropoetiinipreparaadid EE200200037A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US19821699P 1999-07-22 1999-07-22
PCT/US2000/040446 WO2001007075A2 (en) 1999-07-22 2000-07-21 Multi-dose erythropoietin formulations

Publications (1)

Publication Number Publication Date
EE200200037A true EE200200037A (et) 2003-04-15

Family

ID=22732468

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200037A EE200200037A (et) 1999-07-22 2000-07-21 Mitmeannuselised erütropoetiinipreparaadid

Country Status (25)

Country Link
US (1) US7432360B2 (et)
EP (1) EP1200115B9 (et)
JP (1) JP2003517462A (et)
KR (1) KR100693263B1 (et)
CN (2) CN101091792A (et)
AT (1) ATE304863T1 (et)
AU (1) AU777397B2 (et)
BR (1) BR0012667A (et)
CA (1) CA2378945C (et)
CZ (1) CZ302750B6 (et)
DE (1) DE60022759T2 (et)
DK (1) DK1200115T3 (et)
EA (1) EA006220B1 (et)
EE (1) EE200200037A (et)
ES (1) ES2248110T3 (et)
HK (1) HK1050318A1 (et)
HR (1) HRP20020159B1 (et)
HU (1) HUP0202246A3 (et)
IL (2) IL147755A0 (et)
NO (1) NO20020303L (et)
NZ (1) NZ516735A (et)
PL (1) PL202945B1 (et)
RS (1) RS50355B (et)
WO (1) WO2001007075A2 (et)
ZA (1) ZA200200742B (et)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
YU4602A (sh) 1999-07-22 2005-06-10 Aventis Pharmaceuticals Inc. Farmaceutske formulacije zaštićene od dejstva mikroorganizama
ATE291436T2 (de) 2000-05-15 2005-04-15 Hoffmann La Roche Flüssige arzneizubereitung enthaltend ein erythropoietin derivat
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US20050267026A1 (en) * 2004-03-26 2005-12-01 Cheung Wing K Combination dosing regimen for erythropoietin
US7772182B2 (en) 2004-08-05 2010-08-10 Alza Corporation Stable suspension formulations of erythropoietin receptor agonists
EP1845934B1 (de) * 2005-02-03 2008-05-14 Clariant Produkte (Deutschland) GmbH Konservierungsmittel
JP2011116752A (ja) * 2009-10-29 2011-06-16 Jcr Pharmaceuticals Co Ltd エリスロポエチン含有水性液剤
KR101805087B1 (ko) * 2010-09-16 2017-12-05 주식회사 엘지화학 높은 방부력을 제공하는 오일 주사 제형
CA3001429C (en) * 2015-10-22 2023-07-11 Iltoo Pharma Pharmaceutical compositions of il-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3489837A (en) * 1968-07-11 1970-01-13 Leroy J Hyman Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja) 1980-08-25 1985-10-12 林原 健 ヒトエリトロポエチンの製造方法
US4703008A (en) 1983-12-13 1987-10-27 Kiren-Amgen, Inc. DNA sequences encoding erythropoietin
JPS6191131A (ja) * 1984-10-09 1986-05-09 Chugai Pharmaceut Co Ltd 医薬品の吸着防止方法および組成物
JPS6197229A (ja) 1984-10-18 1986-05-15 Chugai Pharmaceut Co Ltd 安定なエリトロポエチン製剤
JPH0651637B2 (ja) * 1985-03-28 1994-07-06 エーザイ株式会社 ペプタイドの吸着防止組成物
US5045529A (en) * 1989-03-27 1991-09-03 Bionostics, Inc. Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) * 1990-06-01 2002-01-21 キリン−アムジエン・インコーポレーテツド 生理活性蛋白含有経口製剤
CA2050425A1 (en) * 1990-09-03 1992-03-04 Yoshiaki Uda Pharmaceutical composition and its mucous use
DE4126983A1 (de) * 1991-08-15 1993-02-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en) 1992-08-06 1997-08-26 Amgen, Inc. Stable and preserved erythropoietin compositions
JP2532025B2 (ja) * 1993-07-23 1996-09-11 株式会社林原生物化学研究所 新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
EP0803255A4 (en) * 1994-06-03 1999-06-30 Tsumura & Co MEDICINAL COMPOSITION
EP0784979A3 (en) * 1996-01-19 1999-03-03 Eli Lilly And Company Obesity protein formulations
IL128941A (en) * 1996-09-13 2007-05-15 Advanced Medicine Res Inst An eye preparation that contains a neurotrophic factor for the treatment of a functional disease of the optic nerve
JPH1112193A (ja) * 1997-06-19 1999-01-19 Sankyo Co Ltd ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) * 1997-12-16 1998-02-11 Smithkline Beecham Plc Vaccine

Also Published As

Publication number Publication date
HRP20020159A2 (en) 2003-06-30
HUP0202246A3 (en) 2010-01-28
NZ516735A (en) 2004-01-30
US7432360B2 (en) 2008-10-07
CZ302750B6 (cs) 2011-10-19
ATE304863T1 (de) 2005-10-15
DE60022759T2 (de) 2006-06-22
YU4702A (sh) 2005-06-10
EP1200115B1 (en) 2005-09-21
HRP20020159B1 (en) 2007-08-31
JP2003517462A (ja) 2003-05-27
CN1371284A (zh) 2002-09-25
HUP0202246A2 (en) 2002-10-28
PL202945B1 (pl) 2009-08-31
WO2001007075A2 (en) 2001-02-01
CA2378945A1 (en) 2001-02-01
CZ2002264A3 (cs) 2002-06-12
ZA200200742B (en) 2003-06-25
KR20020011143A (ko) 2002-02-07
NO20020303D0 (no) 2002-01-21
AU777397B2 (en) 2004-10-14
NO20020303L (no) 2002-03-21
US20050267033A1 (en) 2005-12-01
EA200200073A1 (ru) 2002-08-29
AU7137400A (en) 2001-02-13
EP1200115B9 (en) 2006-01-18
CA2378945C (en) 2010-02-23
IL147755A0 (en) 2002-08-14
CN101091792A (zh) 2007-12-26
HK1050318A1 (zh) 2003-06-20
IL147755A (en) 2009-11-18
RS50355B (sr) 2009-11-10
ES2248110T3 (es) 2006-03-16
KR100693263B1 (ko) 2007-03-13
EA006220B1 (ru) 2005-10-27
WO2001007075A3 (en) 2001-10-04
BR0012667A (pt) 2002-07-02
EP1200115A2 (en) 2002-05-02
PL353569A1 (en) 2003-12-01
DK1200115T3 (da) 2006-01-16
DE60022759D1 (de) 2006-02-02

Similar Documents

Publication Publication Date Title
MXPA02004666A (es) Gelatinas recombinantes.
DK0895776T3 (da) Kosmetisk, lysskærmende præparat
DE60010098D1 (de) 28-epirapaloge
ID23374A (id) Halogenopirimidin
ATE370748T1 (de) Erythropoietin derivate
BR0000327B1 (pt) cabeÇa de poÇo.
DK1091975T3 (da) Ny cyclosporin med forbedret aktivitetsprofil
DK1097173T3 (da) Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
EA199900598A1 (ru) Производные 1-арил- и пиридилпиразола с пестицидными свойствами
NO20020303L (no) Flerdose-erytropoietinpreparater
TR199800105A2 (xx) Tadlar� kaplanm��, antibakteriyel etkili kinolon t�revlerinin �retimi.
DE69616074D1 (de) Ara-c derivate
PT1107793E (pt) Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
ATE241599T1 (de) 25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
EA200000875A1 (ru) Белки, взаимодействующие с каспазой-8
NO20031673D0 (no) Behandling av kreft
TR200003203T2 (tr) Karboksaldehitin saflaştırılması
ATE213236T1 (de) Substituierte benzyloxyimino-verbindungen
MA24582A1 (fr) Nouveaux derives de 4-hydroxy-2h-1-(thio) pyran-2-ones, leurs preparations et leurs utilisations comme rodonticides.
AR026890A1 (es) Composiciones de tenocitos, preparaciones y utilizaciones
DE69705849D1 (de) Herstellung von 3,5-lutidin
DK1173065T3 (da) Anvendelse af cellulosemikrofibriller i fermenterede mælkepræparater
IT1303556B1 (it) Procedimento di preparazione di composti del tipoarilamminoalchilidenemalonati.
FR2752699B1 (fr) Boitier, du type boitier de maquillage

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
GB1A Change in the ownership or in the address of the owner